Fragment-based drug discovery

Similar documents
NMR Solutions for drug discovery

Produktivitätswerkzeuge für die NMR

Intelligent NMR productivity tools

La RMN quantitative appliquée aux petites molécules

Implementation of novel tools to facilitate fragment-based drug discovery by NMR:

Tips & Tricks around temperature

High-resolution probes for 19 F applications. Aitor Moreno Bruker BioSpin, Switzerland BeNeLux NMR User Meeting 2016, Brussels 25 th of November 2016

Tools for Structure Elucidation

Probes and Applications News. Dr. Amy Freund SMASH Torey Pines Hilton, La Jolla, CA Sunday, September 11, 2016

Mnova Software Tools for Fragment-Based Drug Discovery

Natural Products. Innovation with Integrity. High Performance NMR Solutions for Analysis NMR

FRAGMENT SCREENING IN LEAD DISCOVERY BY WEAK AFFINITY CHROMATOGRAPHY (WAC )

Supporting Information. Labeled Ligand Displacement: Extending NMR-based Screening of Protein Targets

NMR Thermometer. Variable Temperature Control Using the 2H Lock System of AVANCE III HD Spectrometers User Manual Version 002

MassHunter Software Overview

Using MnovaScreen to Process, Analyze and Report Ligand-Protein Binding Spectra for Fragment-based Lead Design

Agilent s new solution for obtaining routinely quantitative results from NMR measurements. Magnetic Resonance Systems

InsightXpress 12 Sep Anna Codina, Product Portfolio Manager, Pharma Market, BBIO// Matteo Pennestri, PM InsightXpress, BBIO

MassHunter TOF/QTOF Users Meeting

Operation of the Bruker 400 JB Stothers NMR Facility Department of Chemistry Western University

Laboration 8a. Relaxation, T 1 -measurement with inversion recovery

Automated, High- Throughput Data Processing & Quantification: Illustrated by a series of Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Analytical Roche Benefits and Hurdles of ACD Software. Josef Schneider ACD/Labs Symposium on Laboratory Intelligence Jun 19-20, 2013

CONFOCHECK. Innovation with Integrity. Infrared Protein Analysis FT-IR

Fragment-Based Drug Discovery (FBDD) Using the dispr Technique on Pioneer Systems with OneStep and NeXtStep Injection Methodologies

SPEED AND ACCURACY TO DRUG DEVELOPMENT

Application Note LCMS-112 A Fully Automated Two-Step Procedure for Quality Control of Synthetic Peptides

Protein Dynamics Relaxation techniques

ESPRIT Feature. Innovation with Integrity. Particle detection and chemical classification EDS

Pulsar. Delivering NMR to your benchtop

Everyday NMR. Innovation with Integrity. Why infer when you can be sure? NMR

All Ions MS/MS: Targeted Screening and Quantitation Using Agilent TOF and Q-TOF LC/MS Systems

NMR FACILITY NEWSLETTER

Application Note. Edgar Naegele. Abstract

Automated Illumina TruSeq Stranded mrna library construction with the epmotion 5075t/TMX

Confirmation of In Vitro Nefazodone Metabolites using the Superior Fragmentation of the QTRAP 5500 LC/MS/MS System

Practical QSAR and Library Design: Advanced tools for research teams

Fragment Screening in Drug Discovery

It is possible to choose the temperature for each experiment by setting a temperature under the Temp pane (under the Standard panel).

In silico pharmacology for drug discovery

Agilent MassHunter Quantitative Data Analysis

Highly automated protein formulation development: a case study

Application Note 12: Fully Automated Compound Screening and Verification Using Spinsolve and MestReNova

Agilent MassHunter Quantitative Data Analysis

Band-Selective Homonuclear 2D Correlation Experiments

Rapid and Accurate Forensics Analysis using High Resolution All Ions MS/MS

I690/B680 Structural Bioinformatics Spring Protein Structure Determination by NMR Spectroscopy

Agilent All Ions MS/MS

Filtered/edited NOESY spectra

Meet Stunner: The one-shot protein concentration and sizing combo

Compounding insights Thermo Scientific Compound Discoverer Software

Chemistry Department

Solid State NMR News. Sebastian Wegner, Bruker BioSpin GmbH, Rheinstetten, Germany 40. Deutsches NMR Meeting

Protein Structure Determination using NMR Spectroscopy. Cesar Trinidad

NMR Spectroscopy: A Quantum Phenomena

Automation of Routine Microplate Pipetting and Dispensing

ProMass Deconvolution User Training. Novatia LLC January, 2013

Login -the operator screen should be in view when you first sit down at the spectrometer console:

Ultra-high Resolution in Low Field Tabletop NMR Spectrometers

Undergraduate education with benchtop NMR

EL-GY 6813/BE-GY 6203 Medical Imaging, Fall 2016 Final Exam

BASIC NMR HANDBOOK Written by M. A. Eastman Copyright 1997, 2001, 2013, 2015, 2018

Cerno Bioscience MassWorks: Acquiring Calibration Data on Agilent GC/MSDs

The Development of a Quality Control and Analysis Application for the ThermoFluor High Throughput Screening Assay

Introduction to FBDD Fragment screening methods and library design

North Carolina State University Department of Chemistry Varian NMR Training Manual

Dr. OligoTM DNA / RNA / OLIGO SYNTHESIZERS

Light irradiation experiments with coumarin [1]

Welcome to: Bruker User s Meeting at PANIC

ImprovIng ADmE ScrEEnIng productivity In Drug DIScovEry

In-Solution Digestion: Multi-Plate v1.0 Quick Start Guide

Automated, intelligent sample preparation: Integration of the ESI prepfast Auto-dilution System with the Thermo Scientific icap 7400 ICP-OES

PROTEIN NMR SPECTROSCOPY

Asian Journal of Chemistry; Vol. 25, No. 4 (2013),

PosterREPRINT AN INTERACTIVE PHYSICOCHEMICAL PROPERTY PROFILING SOFTWARE FOR EARLY CANDIDATE ANALYSIS IN DRUG DISCOVERY INTRODUCTION

A Versatile Resolving Agent for Diffusion. Edited Separation of Enantiomers, Complex. Mixtures and Constitutional Isomers

Supporting Information

Agilent MassHunter Profinder: Solving the Challenge of Isotopologue Extraction for Qualitative Flux Analysis

ChiroSolve Enantiomer preparation for discovery, development and manufacturing

Automated Illumina TruSeq Stranded Total RNA library construction with the epmotion 5075t/TMX

Thermo Scientific Pesticide Explorer Collection. Start-to-finish. workflows for pesticide analysis

C NMR Spectroscopy

pyridoxal phosphate synthase

Nuclear Magnetic Resonance

Interferogram and real-time acquisition methods

Physical Background Of Nuclear Magnetic Resonance Spectroscopy

Small-Molecule Kinetics

Supramolecular chemical shift reagents inducing conformational transition: NMR analysis of carbohydrate homooligomer mixtures

Implementing ACD/Automation Server Processing with Micro Flow-Injection and Open-Access NMR

Z -LYTE Assay Setup Guide on the BMG LABTECH CLARIOstar Reader

Human hepatitis B virus surface antigen(hbsag) ELISA Kit

Photochemical synthesis of 3-azabicyclo[3.2.0]heptanes: advanced building blocks for drug discovery

Sensitive NMR Approach for Determining the Binding Mode of Tightly Binding Ligand Molecules to Protein Targets

Metabolite Identification and Characterization by Mining Mass Spectrometry Data with SAS and Python

High-Resolutio n NMR Techniques i n Organic Chemistry TIMOTHY D W CLARIDGE

Nuclear magnetic resonance spectroscopy II. 13 C NMR. Reading: Pavia Chapter , 6.7, 6.11, 6.13

High-throughput Quantification of DNA for NGS Library Prep with the Zephyr G3 Workstation and the VICTOR Nivo Plate Reader

Key Words Q Exactive, Accela, MetQuest, Mass Frontier, Drug Discovery

for XPS surface analysis

I. Proteomics by Mass Spectrometry 1. What is an internal standard and what does it accomplish analytically?

Transcription:

Fragment-based drug discovery Dr. Till Kühn VP Applications Development MRS, Bruker BioSpion User s meeting, Brussels, November 2016 Innovation with Integrity

The principle of Fragment Based Screening from efficient fragments to Drug candidates Fragment high ligand efficiency (LE), medium IC 50 Grow, optimize Candidate high LE, low IC 50 IC 50 : 0.91mM 0.07mM 5.9nM 3.0nM LE: 0.59 0.55 0.49 0.42 Advantages of FBS: Fragment chemical space (10 9 ) << drug like chemical space (10 30 ) Fragment space easier to explore Smaller libraries with higher diversity (~ 1 000 5 000 compounds) Higher hit rates (0.1% - 10%) December 5, 2016 2

NMR in Fragment based Screening % respondents using NMR technique More than one answer possible Summary: FBS is used more and more often NMR is one of the top 2 methods People use more than one technique Ligand and Protein detected NMR used

Fragment Based Screening NMR vs. SPR Throughput Running costs Data Quality Bad samples Data Analysis NMR Fragment Screening 100 samples, 500-1000 compounds per day (19F 3000 compounds/day) (5-10 compounds per sample) Operational costs: ~45k per year (96 well format NMR tubes, cryogens and service contract) QC of fragments possible as part of process, inherent concentration information aids hit validation No issue, one tube per sample: bad sample does not stop the screen Clumsy, home-built acquisition automation, data organization, no workflow support SPR Fragment Screening 500 compounds per day, single point measurement (depends on instrument) Operational costs: 45-50k per year (chips for target immobilization, consumables, solvents and service) No QC of fragments possible during process, independent QC required Sticky compounds may dismantle the chip during screening Easy to use interface for operation, data analysis and export December 5, 2016 4

Two NMR Screening principles Ligand observed methods identify binders from mixtures Protein observed methods identifiy binders and binding site on target - NO isotopic labeling of the protein - NO size limitation of the target - Little amounts of protein needed (4-10 mgs) - Little amounts of ligands needed (0.025 0.250 mm in each sample) - Binding site on target can be identified - Isotopic protein labeling required ( 13 C or 15 N) - Size limitation of target - Amount of protein required depends on application

Two NMR Screening principles Ligand observed methods identify binders from mixtures Protein observed methods identifiy binders and binding site on target - NO isotopic labeling of the protein - NO size limitation of the target - Little amounts of protein needed (4-10 mgs) - Little amounts of ligands needed (0.025 0.250 mm in each sample) - Binding site on target can be identified - Isotopic protein labeling required ( 13 C or 15 N) - Size limitation of target - Amount of protein required depends on application No crystal structure available Binding site in crystal contact (often for PPI targets)

NMR Fragment Based Screening The concept High ligand concentration, low protein concentration Excess of ligand (i.e. 0.25 mm) small molecule, different NMR properties than protein Low protein concentration (i.e. 0.01mM) Large molecule with distinct NMR properties

NMR Fragment Based Screening The concept Ligand in contact with protein (=binding) adopt it s physical properties during residence time Excess of ligand (i.e. 0.25 mm) small molecule, different NMR properties than protein Low protein concentration (i.e. 0.01mM) Large molecule with distinct NMR properties

normalized intensity normalized intensity NMR Fragment Based Screening The concept Binding ligand keeps properties when back in the pool, other ligands are unchanged T 2 T 2 time time

Excursion: Fluorine Fragment Screening Spin-Echo pulse program for relaxation measurement 20 ms relaxation delay 200 ms relaxation delay 20 ms relaxation delay 200 ms relaxation delay 5-19 F-Tryptophan, H 2 O/D 2 O, phosphate buffer, ph 7.4 5-19 F-Tryptophan + Human Serum Albumin, H 2 O/D 2 O, phosphate buffer, ph 7.4 binding fragments: faster relaxation when compared to non-binders

Excursion: Fluorine Fragment Screening Advantages of 19F screening: No water suppression Usually one peak per fragment No buffer signals Up to 30 fragments per mixture Lower compound and protein concentration Increased throughput, higher efficiency

Excursion: Fluorine Fragment Screening typical conditions: protein = 8 µm compound = 20 µm sample volume = 170 µl (3mm tube) measuring time = 8 min 600 MHz QCI-F CryoProbe Courtesy of Dr. M. Blommers, Novartis Pharma, Switzerland

Excursion: Fluorine Fragment Screening Problem: Large Spectral Width Phasing difficult if hard 180 pulses are used

Excursion: Fluorine Fragment Screening Solution: broadband adiabatic refocusing pulse Spin-Echo pulse program for relaxation measurement WHAT WORKS @ 700MHz: 1.5ms Crp90.comp4 Power of 13 us 90-square (19.5kHz) Excitation profile 70kHz = ca. 110ppm 19F @ 700MHz

Excursion: Fluorine Fragment Screening Solution: broadband adiabatic refocusing pulse Spin-Echo pulse program for relaxation measurement WHAT WORKS @ 700MHz: 1.5ms Crp90.comp4 Power of 13 us 90-square (19.5kHz) Excitation profile 70kHz = ca. 110ppm 19F @ 700MHz

Excursion: Fluorine Fragment Screening Benefits of 1H decoupling With 1H decoupling Without 1H decoupling 1 H decoupling significantly improves signal to noise

Excursion: Fluorine Fragment Screening Probe options CryoProbe QCIF 19 F-observe 1 H-decouple 19 F S/N 6000:1 @ 600MHz Smart probe BBFO 19 F-observe, 1 H-decouple 19 F S/N 565:1 @ 600MHz N 2 cooled CryoProbe Prodigy TCI 19 F-observe without 1 H-decoupling 19 F S/N 2400:1 @ 600MHz

Three Basic 1 H NMR Experiments in FBS Water-LOGSY Binders have opposite phase to non-binders Saturation Transfer Difference (STD) Binders show up in difference spectrum, non binders don t T 2 /T 1rho Binders show strong attenuation

NMR FBS in practice You mix several ligands per sample with protein: for higher sample throughput (ligands per sample) AND to identify binding by comparison to non-binder (qualitative aspect) You need a reference spectrum of each individual compound to make the connection to the actual binding molecule Weakly binding Strongly binding Not binding STD reference STD

NMR FBS in practice You mix several ligands per sample with protein: for higher sample throughput (ligands per sample) AND to identify binding by comparison to non-binder (qualitative aspect) You need a reference spectrum of each individual compound to make the connection to the actual binding molecule STD reference STD

NMR FBS in practice You mix several ligands per sample with protein: for higher sample throughput (ligands per sample) AND to identify binding by comparison to non-binder (qualitative aspect) You need a reference spectrum of each individual compound to make the connection to the actual binding molecule STD reference 1. Before screening against any protein, you run each compound of library 2. Then make cocktails 3. Start screening campaigns STD

Screening preparation & library QC on-the-fly CMC-q sets-up, runs and analyzes your references Setup Simple batch setup for the complete library Automation Optimized experiments (auto water suppression etc.) for master stock solutions (DMSO) for ligands in buffer (screening reference) Analysis Fully automated analysis on-the-fly or batch: integrity, concentration, purity, solubility Results All information at a glance Easy cross check and manual editing Spread sheets to sort out bad compounds that don t go into the mixtures December 5, 2016 23

Screening preparation & library QC on-the-fly It actually makes sense to check! Our libraries had ca. 30% bad samples! 20% no compound no compound in stock solution, or not soluble in buffer 10% decayed or wrong compound 50% concentration off by more than +/-30% December 5, 2016 24

Tools for the practical work New temperature control option in SampleJet Individual temperature control for each of the 5 96 sample racks QC of DMSO stock solution QC and reference in buffer The actual protein screening

The actual screening campaign Data acquisition 1. Preparation: run & analyze data for single compound reference (e.g. CMC-q) 2. Mix compound cocktails, document in excel table 3. Run screening campaigns Parameter sets to automatically setup and optimize screening experiments Setup batch run in IconNMR

The actual screening campaign Data analysis and interpretation up to now For each sample, you Open the STD spectrum Open the STD reference Open the Water-LOGSY Open the T2 experiment Open the T2 reference Scale all of them for amplitude Search for, and open all single compound reference spectra for that mixture Before you can start analyzing

The actual screening campaign Data analysis and interpretation TS3.5 next pl With TopSpin 3.5, next pl, you Point to mixture table Indicate directory for single compound reference Indicate parent blank screening data (if applicable). start analyzing!

New FBS tool in Topspin Data analysis and interpretation TS3.5 next pl December 5, 2016 29

New FBS tool in Topspin Data analysis and interpretation TS3.5 next pl December 5, 2016 30

New FBS tool in Topspin Data analysis and interpretation TS3.5 next pl December 5, 2016 31

New FBS tool in Topspin Data analysis and interpretation TS3.5 next pl Customizable Spectra Types by unique identifier

New FBS tool in Topspin Data analysis and interpretation TS3.5 next pl Customizable display layout

New FBS tool in Topspin Data analysis and interpretation TS3.5 next pl December 5, 2016 34

New FBS tool in Topspin Data analysis and interpretation TS3.5 next pl December 5, 2016 35

New FBS tool in Topspin Data analysis and interpretation TS3.5 next pl December 5, 2016 36

New FBS tool in Topspin Data analysis and interpretation TS3.5 next pl Customizable report layout

Summary New tools & experiments for FBS CMC-q to easily run and analyze single compounds in buffer for reference AND do QC on the fly (in buffer to test solubility!) New Parameter sets in TS3.5 pl6 to run optimized FBS experiments in full automation New SampleJet temperature control option to run DMSO samples in one plate, cooled protein samples in the other New tools in IconNMR to setup batches of screening samples quickly from customized Excel spread sheets Brand new FBS tool in TopSpin to help you quickly organize data, analyze it your way and keep track of your results reporting into configurable excel spread sheets December 5, 2016 38

Alavar Gossert, Wolfgang Jahnke, Marcel Blommers, Cesar Fernandez, Paul Erbel Daniel Wyss and Hugh Eaton Bettina Elshorst Markus Schade Stefan Jehle, Pavel Kessler, Fabrice Moriaud, Matteo Penestri, Anna Codina December 5, 2016 39

Innovation with Integrity Thank you for your attention and come see us for demos and discusions Copyright 2011 Bruker Corporation. Corporation. All rights reserved. All rights www.bruker.com reserved.